1. Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa. (16th December 2022) Authors: Sokhela, Simiso; Bosch, Bronwyn; Hill, Andrew; Simmons, Bryony; Woods, Joana; Johnstone, Hilary; Madhi, Shabir; Qavi, Ambar; Ellis, Leah; Akpomiemie, Godspower; Bhaskar, Esther; Levi, Jacob; Falconer, Jonathan; Mirchandani, Manya; Perez Casas, Carmen; Moller, Karlien; Pilkington, Victoria; Pepper... Journal: Open forum infectious diseases Issue: Volume 9:Number 12(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection. (12th August 2022) Authors: Sokhela, Simiso; Bosch, Bronwyn; Hill, Andrew; Simmons, Bryony; Woods, Joana; Johnstone, Hilary; Akpomiemie, Godspower; Ellis, Leah; Owen, Andrew; Casas, Carmen Perez; Venter, Willem Daniel Francois Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 10(2022) Page Start: 2706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗